1. Home
  2. NOTV vs SLAI Comparison

NOTV vs SLAI Comparison

Compare NOTV & SLAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • SLAI
  • Stock Information
  • Founded
  • NOTV 1974
  • SLAI 2001
  • Country
  • NOTV United States
  • SLAI United States
  • Employees
  • NOTV N/A
  • SLAI N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • SLAI EDP Services
  • Sector
  • NOTV Health Care
  • SLAI Technology
  • Exchange
  • NOTV Nasdaq
  • SLAI Nasdaq
  • Market Cap
  • NOTV 46.7M
  • SLAI 39.4M
  • IPO Year
  • NOTV 1997
  • SLAI N/A
  • Fundamental
  • Price
  • NOTV $1.17
  • SLAI $1.93
  • Analyst Decision
  • NOTV Strong Buy
  • SLAI
  • Analyst Count
  • NOTV 1
  • SLAI 0
  • Target Price
  • NOTV $5.00
  • SLAI N/A
  • AVG Volume (30 Days)
  • NOTV 385.3K
  • SLAI 275.0K
  • Earning Date
  • NOTV 12-02-2025
  • SLAI 11-19-2025
  • Dividend Yield
  • NOTV N/A
  • SLAI N/A
  • EPS Growth
  • NOTV N/A
  • SLAI N/A
  • EPS
  • NOTV N/A
  • SLAI N/A
  • Revenue
  • NOTV $505,299,000.00
  • SLAI $24,576,000.00
  • Revenue This Year
  • NOTV $5.64
  • SLAI $14.32
  • Revenue Next Year
  • NOTV $5.16
  • SLAI N/A
  • P/E Ratio
  • NOTV N/A
  • SLAI N/A
  • Revenue Growth
  • NOTV 0.85
  • SLAI N/A
  • 52 Week Low
  • NOTV $1.12
  • SLAI $1.22
  • 52 Week High
  • NOTV $6.48
  • SLAI $8.07
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 34.68
  • SLAI N/A
  • Support Level
  • NOTV $1.12
  • SLAI N/A
  • Resistance Level
  • NOTV $1.43
  • SLAI N/A
  • Average True Range (ATR)
  • NOTV 0.09
  • SLAI 0.00
  • MACD
  • NOTV -0.01
  • SLAI 0.00
  • Stochastic Oscillator
  • NOTV 19.72
  • SLAI 0.00

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About SLAI SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)

SOLAI Ltd is a cryptocurrency mining company. The company aims to build a comprehensive blockchain-based ecosystem that includes AI, stablecoins, payment infrastructure, and Solana treasury and staking operations.

Share on Social Networks: